Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 47 results found. Search for [ sun pharma covid-19 trial ]

Results 1 to 21 of 47
BusinessToday.In
February 3, 2021
India Stock Market News Updates Today: IndusInd Bank, followed by Dr Reddy's, PowerGrid, Tech Mahindra, M&M, Sun Pharma and Axis Bank were among the top gainers. On the other hand, Maruti, Kotak Bank, SBI and UltraTech Cement were among the losers


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


Rupa Burman Roy
September 15, 2020
Traders said equity markets rose higher today following news of a potential COVID-19 vaccine as AstraZeneca resumed its phase-3 trial. Although, gains were capped as traders also awaited the outcome from the US central bank's two-day policy meeting, scheduled on September 15-16


BusinessToday.In
September 15, 2020
India Stock Market Highlights Today: Titan, followed by Sun Pharma, HDFC, ICICI Bank, Bajaj Finance, NTPC, HDFC Bank and M&M were among the major gainers on Sensex pack today. On the other hand, Tech Mahindra, HCL Tech, Kotak Bank, ITC and Bharti Airtel were among the laggards


PB Jayakumar
September 11, 2020
\"It (candidate drug PNB-001) has shown remarkable results in lung inflammation and ARDS (Acute Respiratory Distress Syndrome)\", says PN Balaram, CEO of PNB Vesper


BusinessToday.In
August 20, 2020
India Stock Market Highlights Today: ICICI Bank, followed by IndusInd Bank, HDFC, ITC, Asian Paints and Titan were among the top losers today. On the other hand, NTPC, PowerGrid, Sun Pharma and Infosys were among the gainers.


Chitranjan Kumar
August 10, 2020
Share market updates and analysis for August 11: Factory output data, developments on coronavirus pandemic front and stock specific movements to set tone for stock markets


BusinessToday.In
August 6, 2020
Coronavirus treatment: With the 400 mg FabiFlu, patients could undergo a more relaxed dosage. The company said that reducing pill burden has been a demand from doctors and patients alike


BusinessToday.In
August 4, 2020
FluGuard to be available in market from this week; Sun Pharma to work closely with government and medical community to ensure availability of FluGuard to patients across country


Chitranjan Kumar
July 29, 2020
Share market updates and analysis for July 30: Earnings announcements by Reliance Industries, coronavirus vaccine hopes and US Fed Reserve meeting outcome to set tone for stock markets


BusinessToday.In
July 24, 2020
India Stock Market Highlights Today: HDFC, followed by Axis Bank, Asian Paints, SBI, ICICI Bank, Kotak Bank, IndusInd Bank and HDFC Bank. On the other hand, Sun Pharma, Reliance Industries, Tech Mahindra and Infosys were among the gainers


Chitranjan Kumar
July 21, 2020
Share market updates and analysis for July 22: Corporate earnings announcements, coronavirus vaccine hopes and global cues to set tone for stock markets


BusinessToday.In
July 21, 2020
Vaccine major Serum Institute of India's CEO Adar Poonawalla said on Monday the company will apply for COVID-19 vaccine trials within a week and will soon begin manufacturing the vaccine, developed by Oxford University, in large volumes


Rupa Burman Roy
July 3, 2020
Positive news around the development of a potential coronavirus vaccine and not so weak key economic data from US and China also kept momentum positive  in equity markets worldwide.


BusinessToday.In
July 3, 2020
Cadila Healthcare stock trades mere points away from its 52-week high of Rs 383.65. Cadila Healthcare stock has risen 4.73% in the last 2 sessions


BusinessToday.In
New Delhi, June 13, 2020
COVID-19 vaccine and drug latest news update: Gilead Sciences Inc had previously signed pacts with five other companies for manufacturing and sale of remdesivir; here are latest updates from across world on coronavirus vaccine developments


BusinessToday.In
New Delhi, June 12, 2020
Coronavirus vaccine update: Moderna has said that it has selected a dose for the final stage of clinical trials. It estimated that the trials would begin in July


PB Jayakumar
June 11, 2020
While two such therapies have entered the human clinical trial phase, more are expected in the coming weeks


BusinessToday.In
New Delhi, June 11, 2020
Coronavirus vaccine update: Johnson and Johnson has said that it has pushed up clinical trials by two months; Japanese biotech company AnGes Inc expects its coronavirus vaccine to be ready by the first half of 2021 if production and supply goes smoothly


PB Jayakumar
New Delhi, June 9, 2020
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally


PAGES 1 OF 3  123